Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CONNOLLY, Stuart J")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 102

  • Page / 5
Export

Selection :

  • and

Preventing stroke in patients with atrial fibrillation: Current treatments and new conceptsCONNOLLY, Stuart J.The American heart journal. 2003, Vol 145, Num 3, pp 418-423, issn 0002-8703, 6 p.Article

Role of oral anticoagulation in management of atrial fibrillationCRYSTAL, Eugene; CONNOLLY, Stuart J.Heart (London 1996). 2004, Vol 90, Num 7, pp 813-817, issn 1355-6037, 5 p.Article

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W) : a randomised controlled trial. CommentaryVERHEUQT, Freek W. A; CONNOLLY, Stuart J.Lancet (British edition). 2006, Vol 367, Num 9526, issn 0140-6736, 1877-1878,1903-1912 [12 p.]Article

Left Atrial Appendage Occlusion Does Not Eliminate the Need for WarfarinWHITLOCK, Richard P; HEALEY, Jeff S; CONNOLLY, Stuart J et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 19, pp 1927-1932, issn 0009-7322, 6 p.Article

Atrial fibrillation: Hypertension as a causative agent, risk factor for complications, and potential therapeutic targetHEALEY, Jeff S; CONNOLLY, Stuart J.The American journal of cardiology. 2003, Vol 91, Num 10A, pp 9G-14G, issn 0002-9149Article

Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are UnsuitableCONNOLLY, Stuart J; EIKELBOOM, John W; NG, Jennifer et al.Annals of internal medicine. 2011, Vol 155, Num 9, pp 579-586, issn 0003-4819, 8 p.Article

Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE StudyKOWEY, Peter R; CRIJNS, Harry J. G. M; ALIOT, Etienne M et al.Circulation (New York, N.Y.). 2011, Vol 124, Num 24, pp 2649-2660, issn 0009-7322, 12 p.Article

Dronedarone for Atrial Fibrillation: Have We Expanded the Antiarrhythmic Armamentarium? Authors' replyCONNOLLY, Stuart J; HOHNLOSER, Stefan H; SINGH, David et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 16, pp 1353-1355, issn 0735-1097, 3 p.Article

Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing : Meta-analysis of randomized trials, using individual patient dataHEALEY, Jeffrey S; TOFF, William D; GOLDMAN, Lee et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 1, pp 11-17, issn 0009-7322, 7 p.Article

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation : An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trialsFLAKER, Greg C; GRUBER, Michael; CONNOLLY, Stuart J et al.The American heart journal. 2006, Vol 152, Num 5, pp 967-973, issn 0002-8703, 7 p.Article

Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden deathKRAHN, Andrew D; CONNOLLY, Stuart J; ROBERTS, Robin S et al.The American heart journal. 2004, Vol 147, Num 5, pp 837-840, issn 0002-8703, 4 p.Article

Asymptomatic or silent atrial fibrillation: Frequency in untreated patients and patients receiving azimilidePAGE, Richard L; TILSCH, Thomas W; CONNOLLY, Stuart J et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 8, pp 1141-1145, issn 0009-7322, 5 p.Article

Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic PacingNEWMAN, David; CHING LAU; TANG, Anthony S. L et al.The American heart journal. 2003, Vol 145, Num 3, pp 430-437, issn 0002-8703, 8 p.Article

Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)CRYSTAL, Eugene; KAHN, Shoshanah; ROBERTS, Robin et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 125, Num 3, pp 633-637, issn 0022-5223, 5 p.Article

Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. A meta-analysisCRYSTAL, Eugene; CONNOLLY, Stuart J; SLEIK, Khaled et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 1, pp 75-80, issn 0009-7322Article

Challenges of establishing new antithrombotic therapies in atrial fibrillationCONNOLLY, Stuart J; EIKELBOOM, John; O'DONNELL, Martin et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 4, pp 449-455, issn 0009-7322, 7 p.Article

Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practiceEMMERICH, Joseph; LE HEUZEY, Jean-Yves; BATH, Philip M. W et al.European heart journal supplements. 2005, Vol 7, Num C, pp C28-C33, issn 1520-765XArticle

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial AnalysisHIJAZI, Ziad; HOHNLOSER, Stefan H; WALLENTIN, Lars et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 9, pp 961-970, issn 0009-7322, 10 p.Article

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) TrialDANS, Antonio L; CONNOLLY, Stuart J; YUSUF, Salim et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 5, pp 634-640, issn 0009-7322, 7 p.Article

Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY TrialHART, Robert G; DIENER, Hans-Christoph; SEAN YANG et al.Stroke (1970). 2012, Vol 43, Num 6, pp 1511-1517, issn 0039-2499, 7 p.Article

Relevance of Electrical Remodeling in Human Atrial Fibrillation: Results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial Mechanisms of Atrial Fibrillation StudyHEALEY, Jeff S; ISRAEL, Carsten W; CARLSON, Mark et al.Circulation. Arrhythmia and electrophysiology. 2012, Vol 5, Num 4, pp 626-631, issn 1941-3149, 6 p.Article

Apixaban in Patients with Atrial FibrillationCONNOLLY, Stuart J; EIKELBOOM, John; TALAJIC, Mario et al.The New England journal of medicine. 2011, Vol 364, Num 9, pp 806-817, issn 0028-4793, 12 p.Article

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) TrialEIKELBOOM, John W; WALLENTIN, Lars; DIENER, Hans-Christoph et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 21, pp 2363-2372, issn 0009-7322, 10 p.Article

Dronedarone in patients with congestive heart failure: insights from ATHENAHOHNLOSER, Stefan H; CRIJNS, Harry J. G. M; VAN EICKELS, Martin et al.European heart journal. 2010, Vol 31, Num 14, pp 1717-1721, issn 0195-668X, 5 p.Article

Cognitive Function and Anticoagulation Control in Patients With Atrial FibrillationFLAKER, Greg C; POGUE, Janice; YUSUF, Salim et al.Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 3, pp 277-283, issn 1941-7713, 7 p.Article

  • Page / 5